Your browser doesn't support javascript.
loading
The Postpartum Period Can Worsen Myelin Oligodendrocyte Glycoprotein Antibody-associated Encephalomyelitis.
Yamamoto, Shizuka; Yano, Mitsutake; Miyamoto, Yuko; Hanaoka, Takuya; Nishida, Yoshihiro; Kawano, Yasushi.
Afiliação
  • Yamamoto S; Department of Obstetrics and Gynecology, Faculty of Medicine, Oita University, Japan.
  • Yano M; Department of Obstetrics and Gynecology, Faculty of Medicine, Oita University, Japan.
  • Miyamoto Y; Department of Obstetrics and Gynecology, Faculty of Medicine, Oita University, Japan.
  • Hanaoka T; Department of Neurology, Faculty of Medicine, Oita University, Japan.
  • Nishida Y; Department of Obstetrics and Gynecology, Faculty of Medicine, Oita University, Japan.
  • Kawano Y; Department of Obstetrics and Gynecology, Faculty of Medicine, Oita University, Japan.
Intern Med ; 62(7): 1063-1066, 2023 Apr 01.
Article em En | MEDLINE | ID: mdl-36070939
ABSTRACT
Myelin oligodendrocyte glycoprotein (MOG) antibodies are associated with relapsing inflammatory demyelinating disease. Pregnancy complicates the disease course, potentially leading to either symptom improvement or worsening. A 28-year-old woman with MOG antibody-associated encephalomyelitis had 2 pregnancies; her disease worsened during both postpartum periods despite continuing prednisolone and levetiracetam. The umbilical cord blood was positive for MOG antibodies following her second pregnancy, but neither baby had MOG antibody-associated disease. This is the first case report of MOG antibody-associated demyelinating disease that worsened postpartum despite continuous medication. Furthermore, we observed the placental transfer of MOG antibodies for the first time.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Desmielinizantes / Encefalomielite Tipo de estudo: Risk_factors_studies Limite: Female / Humans / Pregnancy Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Desmielinizantes / Encefalomielite Tipo de estudo: Risk_factors_studies Limite: Female / Humans / Pregnancy Idioma: En Ano de publicação: 2023 Tipo de documento: Article